PD-L1 anticorps
Aperçu rapide pour PD-L1 anticorps (ABIN7266180)
Antigène
Voir toutes PD-L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- PD-L1/CD274 Rabbit mAb
-
Réactivité croisée
- Humain
-
Attributs du produit
- Monoclonal Antibodies
-
Purification
- Affinity purification
-
Pureté
- ≥95 % purity by SDS-PAGE
-
Immunogène
- Recombinant protein of human PD-L1/CD274.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Elisa,1:500 - 1:2000,WB,1:500 - 1:2000,FC,1:50 - 1:200,Inhibition,1 μg/ul
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.09 % sodium azide, 50 % glycerol, pH 7.4.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PD-L1 (CD274 (PD-L1))
-
Autre désignation
- PD-L1
-
Sujet
- Programmed death-ligand 1 (PD-L1) is a 40 kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and non-hematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1-PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PD-L1 has become an important biomarker and immunotherapy target for many types of malignancies.,B7-H,B7H1,PDL1,PD-L1,PDCD1L1,PDCD1LG1,CD274,Immunology & Inflammation,CD markers,PD-L1
-
Poids moléculaire
- 20kDa/33kDa
-
ID gène
- 29126
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Antigène
-